Medtronic plc, a global leader in medical technology, develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. With a focus on improving patient outcomes, the company's Cardiovascular Portfolio segment offers a range of implantable cardiac devices, ablation products, monitoring systems, and patient-centered software. Additionally, their Medical Surgical Portfolio includes surgical stapling devices, electrosurgery products, and robotic-assisted surgery products, among other therapies. Medtronic's Neuroscience Portfolio offers products for a variety of specialists, including spinal surgeons, pain management specialists, and interventional radiologists. Finally, their Diabetes Operating Unit provides insulin pumps, continuous glucose monitoring systems, and smart insulin pen systems. Founded in 1949 and headquartered in Dublin, Ireland, Medtronic continues to drive innovation in the medical technology industry.